The Neuromyelitis Optica Spectrum Disorder (NMOSD) Market growth at a CAGR of 6.10% & expected USD 651.84 million by 2029. It is analyzed as type, treatment type, diagnosis, dosage form, route of administration, end-users and distribution channel.